688488.SS
Jiangsu Aidea Pharmaceutical Group Co., Ltd.
ShanghaiCNYEQUITY
Healthcare
DELAYED
Last price
16.85
▲ 0.36 (2.18%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
16.78
Prev close
16.49
Day high
16.88
Day low
16.49
Volume
1.20M
Market cap
$7.09B
P/E (TTM)
—
52W range
11.40 – 22.55
Day trading desk
Gap from prior close
+1.76%
Prior close 16.49
VWAP
16.72
+0.76% from price
Relative volume
0.08×
Quiet session
Session range
2.18%
16.51 – 16.87
Position in range
94%
Near session high
ATR (14D)
1.19
7.08% of price
Prior day high
17.37
PDH
Prior day low
16.36
PDL
Bid / ask spread
—
Quote not published
Session volume
913.50K
Avg 10.85M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-4.86%
-3.5%
1M
+12.33%
+8.6%
3M
+11.29%
+8.2%
6M
+0.54%
-10.5%
YTD
+3.18%
-9.1%
1Y
+4.85%
-15.1%
3Y
+42.31%
-31.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 688488.SS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
209.01M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Dec 27, 24 | Fu (Heliang) Chairman of the Board |
BUY | 233.79K | $306.22K | Direct |
| Dec 27, 24 | Zhange (Jie) Chief Executive Officer |
BUY | 82.86K | $108.52K | Direct |
| Dec 27, 24 | Fu (Heliang) Chairman of the Board |
BUY | 233.79K | $306.22K | Direct |
| Dec 27, 24 | Zhange (Jie) Chief Executive Officer |
BUY | 82.86K | $108.52K | Direct |
| Oct 22, 24 | Wang (Jun) Chief Operating Officer |
SELL | 623.76K | $800.35K | Direct |
| Oct 22, 24 | Wang (Jun) Chief Operating Officer |
SELL | 623.76K | $800.35K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Fu (Heliang) |
Chairman of the Board | 2.75M | Acquisition |
Wang (Jun) |
Chief Operating Officer | 2.08M | Sale |
Zhange (Jie) |
Chief Executive Officer | 112.86K | Acquisition |
Fundamentals
Market cap$7.09B
Enterprise value$7.24B
Revenue (TTM)$699.33M
Gross profit$460.79M
EBITDA$82.99M
Net income$-27.51M
EPS (TTM)$-0.07
Free cash flow$-48.06M
Total cash$534.06M
Total debt$719.92M
Book value / share$2.32
Shares outstanding420.78M
Float208.39M
Short % of float—
Dividend yield—
Beta (5Y)0.47
Valuation & profitability ratios
Trailing P/E—
Forward P/E52.66
PEG ratio—
Price / sales—
Price / book7.28
EV / revenue10.35
EV / EBITDA87.23
Gross margin65.89%
Operating margin11.85%
Profit margin-3.93%
Return on equity-0.31%
Return on assets0.93%
Debt / equity66.07
Current ratio1.50
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $719.17M | $417.80M | $411.36M | $244.22M | +72.1% |
| Operating revenue | $719.17M | $417.80M | $411.36M | $244.22M | +72.1% |
| Cost of revenue | $238.82M | $188.29M | $221.34M | $139.45M | +26.8% |
| Gross profit | $480.35M | $229.51M | $190.03M | $104.77M | +109.3% |
| Research & development | $87.37M | $89.89M | $63.18M | $63.91M | -2.8% |
| Selling, general & admin | $221.18M | $147.66M | $97.82M | $84.67M | +49.8% |
| Total operating expense | $419.05M | $336.15M | $258.44M | $218.98M | +24.7% |
| Operating income | $61.30M | -$106.64M | -$68.42M | -$114.21M | +157.5% |
| Net interest income | -$13.62M | -$12.96M | -$10.35M | -$1.28M | -5.0% |
| Pre-tax income | $24.64M | -$166.00M | -$92.09M | -$142.38M | +114.8% |
| Tax provision | $16.56M | -$27.16M | -$16.02M | -$18.29M | +161.0% |
| Net income | -$19.53M | -$141.20M | -$76.07M | -$124.09M | +86.2% |
| Net income to common | -$19.53M | -$141.20M | -$76.07M | -$124.09M | +86.2% |
| Basic EPS | -0.05 | -0.34 | -0.18 | -0.30 | +85.3% |
| Diluted EPS | -0.05 | -0.34 | -0.18 | -0.30 | +85.3% |
| EBIT | $40.26M | -$150.64M | -$80.32M | -$138.47M | +126.7% |
| EBITDA | $95.82M | -$97.46M | -$35.22M | -$100.61M | +198.3% |
| Basic shares | 390.65M | 415.31M | 422.61M | 413.64M | -5.9% |
| Diluted shares | 390.65M | 415.31M | 422.61M | 413.64M | -5.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $371.16M | $335.34M | $225.36M | $134.91M | +10.7% |
| Cash & short-term investments | $451.35M | $441.52M | $441.10M | $486.54M | +2.2% |
| Accounts receivable | $151.41M | $139.14M | $182.42M | $113.83M | +8.8% |
| Inventory | $259.49M | $254.97M | $184.88M | $156.15M | +1.8% |
| Total current assets | $938.74M | $894.93M | $872.38M | $802.46M | +4.9% |
| Property, plant & equipment | $404.26M | $434.45M | $443.54M | $447.18M | -6.9% |
| Goodwill & intangibles | $361.80M | $352.02M | $204.45M | $194.31M | +2.8% |
| Total assets | $1.91B | $1.87B | $1.75B | $1.66B | +2.3% |
| Total current liabilities | $709.21M | $649.06M | $491.57M | $331.68M | +9.3% |
| Current debt | $365.18M | $220.50M | $255.55M | $145.16M | +65.6% |
| Long-term debt | $71.74M | $90.51M | $69.94M | $60.00M | -20.7% |
| Total debt | $559.15M | $488.03M | $412.30M | $208.77M | +14.6% |
| Total liabilities | $839.37M | $802.48M | $621.03M | $456.57M | +4.6% |
| Retained earnings | -$354.19M | -$334.65M | -$193.45M | -$117.38M | -5.8% |
| Shareholder equity | $964.68M | $980.89M | $1.13B | $1.20B | -1.7% |
| Working capital | $229.53M | $245.87M | $380.81M | $470.78M | -6.6% |
| Net tangible assets | $602.88M | $628.87M | $921.09M | $1.00B | -4.1% |
| Shares issued | 420.78M | 420.78M | 420.78M | 420.00M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $8.08M | -$138.84M | -$76.07M | -$124.09M | +105.8% |
| Depreciation & amortisation | $55.56M | $53.17M | $45.10M | $37.85M | +4.5% |
| Change in working capital | -$70.17M | -$10.72M | -$160.18M | -$41.05M | -554.3% |
| Operating cash flow | $17.63M | -$37.50M | -$166.22M | -$92.55M | +147.0% |
| Capital expenditure | -$47.93M | -$44.56M | -$71.20M | -$140.30M | -7.6% |
| Investing cash flow | -$26.63M | $85.10M | $73.44M | -$405.72M | -131.3% |
| Dividends paid | -$20.87M | -$15.85M | -$11.66M | -$3.47M | -31.7% |
| Financing cash flow | $50.04M | $54.86M | $190.78M | $196.03M | -8.8% |
| Free cash flow | -$30.30M | -$82.06M | -$237.43M | -$232.85M | +63.1% |
| End cash position | $365.20M | $324.26M | $221.80M | $123.80M | +12.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $178.02M | $166.77M | $164.62M | $197.86M | $118.93M | +6.7% |
| Operating revenue | $178.02M | $166.77M | $164.62M | $197.86M | $118.93M | +6.7% |
| Cost of revenue | $57.83M | $49.47M | $49.65M | $75.11M | $47.25M | +16.9% |
| Gross profit | $120.19M | $117.30M | $114.98M | $122.75M | $71.68M | +2.5% |
| Research & development | $13.46M | $22.37M | $25.89M | $15.71M | $25.87M | -39.8% |
| Selling, general & admin | $86.11M | -$43.46M | $27.08M | $81.55M | -$12.73M | +298.1% |
| Total operating expense | $99.73M | $91.68M | $112.45M | $97.64M | $121.99M | +8.8% |
| Operating income | $20.47M | $25.62M | $2.53M | $25.11M | -$50.31M | -20.1% |
| Net interest income | -$3.98M | -$3.37M | -$3.27M | -$3.54M | -$3.42M | -18.2% |
| Pre-tax income | $15.85M | -$1.98M | $1.01M | $31.56M | -$87.50M | +899.5% |
| Tax provision | $1.66M | $6.05M | $127.02K | $5.95M | -$10.39M | -72.6% |
| Net income | $7.61M | -$12.69M | -$6.39M | $15.58M | -$80.26M | +159.9% |
| Net income to common | $7.61M | -$12.69M | -$6.39M | $15.58M | -$80.26M | +159.9% |
| Basic EPS | 0.02 | — | — | 0.04 | — | — |
| Diluted EPS | 0.02 | — | — | 0.04 | — | — |
| EBIT | $20.05M | $1.72M | $4.85M | $35.81M | -$83.27M | +1,066.0% |
| EBITDA | $20.05M | $1.72M | $4.85M | $35.81M | -$83.27M | +1,066.0% |
| Basic shares | 380.31M | — | — | 389.55M | — | — |
| Diluted shares | 380.31M | — | — | 389.55M | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $503.95M | $371.16M | $377.62M | $422.73M | $335.34M | +35.8% |
| Cash & short-term investments | $534.06M | $451.35M | $472.90M | $452.87M | $441.52M | +18.3% |
| Accounts receivable | $146.65M | $151.41M | $140.89M | $127.35M | $139.14M | -3.1% |
| Inventory | $257.92M | $259.49M | $266.39M | $271.74M | $254.97M | -0.6% |
| Total current assets | $1.01B | $938.74M | $956.38M | $923.05M | $894.93M | +7.9% |
| Property, plant & equipment | $402.47M | $404.26M | $418.46M | $425.14M | $434.45M | -0.4% |
| Goodwill & intangibles | $365.57M | $361.80M | $345.36M | $350.84M | $352.02M | +1.0% |
| Total assets | $2.06B | $1.91B | $1.92B | $1.90B | $1.87B | +7.6% |
| Total current liabilities | $675.68M | $709.21M | $681.98M | $656.83M | $649.06M | -4.7% |
| Current debt | $428.11M | $365.18M | $329.16M | $280.13M | $220.50M | +17.2% |
| Long-term debt | $231.24M | $71.74M | $87.72M | $83.33M | $90.51M | +222.3% |
| Total debt | $719.92M | $559.15M | $533.05M | $481.83M | $488.03M | +28.8% |
| Total liabilities | $969.26M | $839.37M | $832.33M | $802.64M | $802.48M | +15.5% |
| Retained earnings | -$346.58M | -$354.19M | -$325.46M | -$319.07M | -$334.65M | +2.1% |
| Shareholder equity | $974.51M | $964.68M | $989.84M | $996.36M | $980.89M | +1.0% |
| Working capital | $337.02M | $229.53M | $274.40M | $266.22M | $245.87M | +46.8% |
| Net tangible assets | $608.94M | $602.88M | $644.48M | $645.52M | $628.87M | +1.0% |
| Shares issued | 420.78M | 420.78M | 420.78M | 420.78M | 420.78M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$7.83M | -$29.53M | -$6.06M | -$10.54M | — | +73.5% |
| Investing cash flow | $42.55M | -$32.17M | -$72.42M | $64.13M | $33.17M | +232.2% |
| Dividends paid | -$4.08M | -$4.32M | -$8.53M | -$4.20M | -$4.87M | +5.6% |
| Financing cash flow | $81.62M | $70.27M | $41.97M | -$10.52M | -$320.76K | +16.2% |
| Free cash flow | -$6.94M | -$39.39M | -$21.37M | $29.22M | -$32.98M | +82.4% |
| End cash position | $490.19M | $365.20M | $371.86M | $417.62M | $324.26M | +34.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders49.67%
Held by institutions13.59%
Institutions holding49
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
17.30
-2.62% from price
SMA 20
16.22
+3.91% from price
SMA 50
14.99
+12.38% from price
SMA 100
15.76
+6.91% from price
SMA 200
15.83
+6.44% from price
EMA 12
16.90
-0.32% from price
EMA 26
16.29
+3.42% from price
EMA 50
15.77
+6.83% from price
RSI (14)
54.0
Neutral
MACD (12,26,9)
0.61
Hist -0.04
ATR (14)
1.19
7.08% of price
Realised vol 30D
81.3%
Annualised
Bollinger upper
19.29
20, 2σ
Bollinger lower
13.14
20, 2σ
50 / 200 cross
Death
14.99 vs 15.83
Trend bias
Above 200
+6.44%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.44
Less volatile than market
Correlation to SPY
0.09
Largely independent
Realised vol 30D
81.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-47.7%
Peak to trough
Max drawdown 5Y
-65.0%
Peak to trough
ATR 14
1.19
7.08% of price
Beta (reported)
0.47
5Y monthly, from filing
Headlines
Dow Jones Futures Waver; Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 11m ago
Gold, silver rally off ugly crash, but investors remain on edge
TheStreet · 14m ago
Gauff powers past Pegula to win US Open warm-up in Cincinnati
AFP · 15m ago
Shein to make market debut in Hong Kong in September
AFP · 18m ago
Alibaba set to open down 8% in Hong Kong after $10.2 billion share placement plan
Reuters · 19m ago
RKLB Stock Rockets Toward Best Month Since May: ‘Hungry Hippo’ Begins Flight-Like Testing Ahead Of Neutron Debut
Stocktwits · 20m ago
Japan's Olympic figure skating heroes to wed
AFP · 22m ago
Fils tops Tiafoe to claim first ATP Masters title in Cincinnati
AFP · 29m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.